Clarksville, TN Online: News, Opinion, Arts & Entertainment.


Topic: Chloroquine Phosphate

FDA Coronavirus (COVID-19) Update: August 6th, 2020

 

U.S. Food and Drug Administration (FDA)Silver Spring, MD – The U.S. Food and Drug Administration reports the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:

The FDA issued its first warning letter to New Life International and its second warning letter to Fishman Chemical of North Carolina, LLC, both of which distribute chloroquine phosphate products intended to treat disease in aquarium fish.

Coronavirus

Coronavirus

«Read the rest of this article»

Sections: News | No Comments
 

FDA Coronavirus (COVID-19) Update: June 16th, 2020

 

U.S. Food and Drug Administration (FDA)Silver Spring, MDThe U.S. Food and Drug Administration is continuing  to take action in the ongoing response to the COVID-19 Coronavirus pandemic:

Today, FDA revoked the emergency use authorization (EUA) that allowed for chloroquine phosphate and hydroxychloroquine sulfate donated to the Strategic National Stockpile to be used to treat certain hospitalized patients with COVID-19 Coronavirus when a clinical trial was unavailable, or participation in a clinical trial was not feasible.

Coronavirus

Coronavirus

«Read the rest of this article»

Sections: News | No Comments
 

FDA Coronavirus (COVID-19) Update: April 17th, 2020

 

U.S. Food and Drug Administration - FDASilver Spring, MDThe U.S. Food and Drug Administration (FDA) has announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:

The FDA provided an update on one potential treatment called convalescent plasma and is encouraging those who have recovered from COVID-19 Coronavirus to donate plasma to help others fight this disease. Convalescent plasma is an antibody-rich product made from blood donated by people who have recovered from the disease caused by the virus.

Coronavirus

Coronavirus

«Read the rest of this article»

Sections: News | No Comments
 


FDA Coronavirus (COVID-19) Update: April 14th, 2020

 

U.S. Food and Drug Administration - FDASilver Spring, MDThe U.S. Food and Drug Administration (FDA) has announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:

Given the anticipated increase in demand for chloroquine phosphate and hydroxychloroquine sulfate, the FDA is taking steps to ensure that adequate supply of these drug products is available for patients.

Coronavirus

Coronavirus

«Read the rest of this article»

Sections: News | No Comments
 



  • Visit Us On FacebookVisit Us On TwitterVisit Us On PinterestVisit Us On YoutubeCheck Our FeedVisit Us On Instagram
  • Personal Controls